Health Care Counsel Blog
843 total results. Page 1 of 34.
Anne M. Murphy, Stephen Blake
How Massachusetts senior living providers need to be thinking about the recently enacted Long Term Care Reform Law and a recent Centers for Medicare & Medicaid Services audit of nursing homes.
D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, John M. Hindley, Laura Zell
Headlines that Matter for Companies and Executives in Regulated Industries
D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Rebecca W. Foreman, Laura Zell
Headlines that Matter for Companies and Executives in Regulated Industries
D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Rebecca W. Foreman, Roberto Martinez
Headlines that Matter for Companies and Executives in Regulated Industries
Gayland O. Hethcoat II, M.H. Joshua Chiu
In a significant move toward regulating artificial intelligence (AI) in health care, Assembly Bill (AB) 3030 will require health facilities, clinics, and physician practices in California to provide disclaimers to patients about their use of generative AI (GenAI).
Debra Albin-Riley, Lowell C. Brown, M.H. Joshua Chiu
Expanding on the peer review protections established in Bonni v. St. Joseph Health System, the California Court of Appeal in Dignity Health v. Mounts held that a wide array of medical staff communications regarding peer review and patient care are absolutely protected from legal liability.
D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Shoshana Golden, Roberto Martinez
Headlines that Matter for Companies and Executives in Regulated Industries
D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Mattie Bowden, Shoshana Golden, John M. Hindley
Headlines that Matter for Companies and Executives in Regulated Industries
Thomas E. Jeffry, Jr., Gayland O. Hethcoat II
On September 28, California Governor Gavin Newsom vetoed Assembly Bill (AB) 3129. The proposed law sought to regulate health care transactions involving private equity and hedge funds.
D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Mattie Bowden, Elizabeth Satarov
Headlines that Matter for Companies and Executives in Regulated Industries
D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Rebekkah R.N. Stoeckler, Elizabeth Satarov
Headlines that Matter for Companies and Executives in Regulated Industries
Caroline Turner English, Alison Lima Andersen, Pascal Naples, Mattie Bowden
On September 9, the US Departments of Labor, Treasury, and Health and Human Services (the Departments) jointly released a final rule to ensure that group health plans comply with the Mental Health Parity and Addiction Equity Act (MHPAEA).
D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Roberto Martinez, Rebekkah R.N. Stoeckler
Headlines that Matter for Companies and Executives in Regulated Industries
D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Roberto Martinez, Heather M. Zimmer
Headlines that Matter for Companies and Executives in Regulated Industries
Douglas A. Grimm, Stephanie Trunk, Gayland O. Hethcoat II, Shoshana Golden
In 2021, we provided an overview of multiple federal lawsuits challenging the US Department of Health and Human Services (HHS) Health Resources and Services Administration’s (HRSA) enforcement of the 340B Drug Pricing Program, particularly with respect to contract pharmacies.
Michael K. Molzberger, Linda M. Jackson, Matthew F. Prewitt, Alexandra M. Romero, Lauren C. Schaefer
On August 20, the US District Court for the Northern District of Texas held that the Federal Trade Commission’s (FTC) final rule banning noncompetes is unlawful and “set aside” the rule.
Gayland O. Hethcoat II, Moyosore O. Koya
On June 20, a federal district court in Texas ruled that the US Department of Health and Human Services (HHS) Office for Civil Rights (OCR) exceeded its authority under the Health Insurance Portability and Accountability Act (HIPAA).
D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Mattie Bowden, Shoshana Golden
Headlines that Matter for Companies and Executives in Regulated Industries
Caroline Turner English, David S. Greenberg, Oluwaseun (Shay) Wells
In a recent opinion, Smith et al. v. UnitedHealth Group Inc. et al., the US Court of Appeals for the Eighth Circuit affirmed the dismissal of an Employee Retirement Income Security Act (ERISA) class action suit brought by health plan participants.
D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Shoshana Golden, Elizabeth Satarov
Headlines that Matter for Companies and Executives in Regulated Industries
D. Jacques Smith, Hillary M. Stemple, Pascal Naples
The US Supreme Court recently overturned its ruling in Chevron USA, Inc. v. Natural Resources Defense Council, Inc., changing the landscape for federal agency rulemaking and actions, particularly in the health care industry.
In July 2023, US Senators Michael Bennet (D-CO) and Chuck Grassley (R-IA), along with US Representatives Lori Trahan (D-MA) and Mariannette Miller-Meeks (R-IA), introduced legislation to improve access to critical care for children with complex medical conditions that may not be available in their home state.
D. Jacques Smith, Nadia Patel, Rebecca W. Foreman, Roberto Martinez
On June 7, Adam Hart, a former employee of McKesson Corporation, filed a petition for certiorari to the US Supreme Court.
Stephanie Trunk, Shoshana Golden
Pharma’s favorite summer pastime is back again: reviewing the Centers for Medicare & Medicaid Services (CMS) release of the 2025 proposed Hospital Outpatient Prospective Payment System (HOPPS) and Physician Fee Schedule (PFS) rules.
Douglas A. Grimm, Lowell C. Brown, David S. Greenberg, Pascal Naples
On June 28, the US Supreme Court overturned the Chevron doctrine — the legal principle that the judiciary should defer to a federal agency’s reasonable interpretation of an ambiguous statute.